Analogs nke ọgwụ metglib ọgwụ


A na - egosiputa analogues nke ọgwụ ọgwụ metglib, nke a na - agbanwe agbanwe na-emetụta nsonaazụ nke ahụ nwere nkwanye otu ma ọ bụ karịa. Mgbe ị na-ahọrọ okwu ntụgharị, tụlee ọ bụghị naanị ọnụ ahịa ha, kamakwa mba mmepụta na aha onye mere ya.
  1. Nkọwapụta ọgwụ ọjọọ
  2. Ndepụta analogues na ọnụahịa
  3. Nyocha
  4. Ntụziaka gọọmentị maka ojiji

Nkọwapụta ọgwụ ọjọọ

Metglib Force - Oral jikọtara hypoglycemic gị n'ụlọnga, usoro nke sulfonylurea nke ọgbọ nke abụọ.

Ọ nwere nsonji akwara na extrapancreatic.

Glibenclamide na-akpali mkpali insulin site na iwetula ọnụ ụzọ maka mgbakasị glucose beta-cell, na-eme ka nnabata insulin na njikọta ya na mkpụrụ ndụ, na-abawanye ntọhapụ insulin, na-eme ka mmetụta insulin na-enwe n’arụ na umeji ume, na-egbochi lipolysis na adipose anụ ahụ. Ọrụ nke abụọ nke insulin insulin.

Metformin na - egbochi gluconeogenesis n'ime imeju, na - ebelata nnabata nke glucose na eriri afọ ma na - abawanye uru ya na anụ ahụ, belata ọdịnaya TG na cholesterol n'ime ọbara. Na-eme ka njikọta insulin na-anabata ndị na-anabata ya (ọ bụrụ na insulin adịghị n'ọbara, anaghị egosipụta ọgwụgwọ ọgwụgwọ). Emeghị mmeghachi omume hypoglycemic.

Mmetụta hypoglycemic na-etolite mgbe elekere 2 gachara ma were awa iri na abụọ.

Ndepụta nke analogues


Mpempe mwepụta (site na ama ama)Ọnụahịa, tee.
Metglib Force
Mbadamba ụrọ mkpuchi 5 mg + 500 mg, 30 PC.144
Mbadamba ụrọ mkpuchi 2,5 mg + 500 mg, 30 PC.161
Bagomet Plus
Glibenclamide + Metformin
Glibenclamide + Metformin * (Glibenclamide + Metformin)
Glibenfage
Glibomet
Tab N40 (Berlin - Chemie AG (Germany)367.30
Ndị Gris
Tab 500mg / 2.5mg Nke 30 (Merck Santé SAA (France)307.80
Tab 500mg / 5mg Nke 30 (Merck Santé SAA (France)313.50
Gluconorm
2,5 mg + 400 mg Nke 40 tab (M.J. Biofarm Pvt. Ltd. (India)226.90
Gluconorm Plus
Mbadamba ụrọ mkpuchi 2,5 mg + 500 mg, 30 PC.154
Mbadamba ụrọ mkpuchi 5 mg + 500 mg, 30 PC.156
Metglib
Mbadamba ụrọ mkpuchi 2,5 mg + 400 mg, 40 PC.199

Ndị ọbịa iri kwuru na iri nri ụbọchị ọ bụla

Ugboro ole ka ị ga-ewere Metglib Force?
Ọtụtụ ndị na-aza ya na-a drugụ ọgwụ a ugboro abụọ n'ụbọchị. Akuko a gosiputara ugboro ole ndi ozo zara ya ogwu.
Ndị otu%
Ugboro abụọ n'ụbọchị550.0%
Otu ugboro n'ụbọchị330.0%
3 ugboro n'ụbọchị2

Ndị ọbịa isii kọrọ banyere usoro ọgwụgwọ ha

Ndị otu%
201-500mg3
50.0%
1-5mg233.3%
501mg-1g1

Ndị ọbịa abụọ kọrọ akụkọ ụbọchị ha gwụsịrị

Ogologo oge ole ka ọ na-ewe iji Metglib Force iji nweta mmelite n'ọnọdụ ọnọdụ onye ọrịa?
Ndị sonyere na nyocha ahụ n'ọtụtụ oge ka ụbọchị abụọ gachara nwere nkwalite. Ma nke a nwere ike ọ gaghị adakọ oge ị ga - emeziwanye. Gwa dọkịta gị ogologo oge ịchọrọ ị thisụ ọgwụ a. Tebụl dị n'okpuru ebe a na-egosi nsonaazụ nke nyocha na mmalite nke ihe dị irè.
Ndị otu%
2 ikp150.0%
1 ikp1

Ndị ọbịa anọ kwuru oge nnabata

Kedu oge kachasị mma iji were Metglib Force: na afọ na-enweghị isi, tupu, mgbe, ma ọ bụ jiri nri?
Ndị ọrụ saịtị na-akọkarị na ị takingụ ọgwụ a na nri. Agbanyeghị, dọkịta nwere ike ịkwado oge ọzọ. Akuko ahụ gosipụtara mgbe ndị ọrịa ndị ọzọ gbara ajụjụ ọnụ na-a theụ ọgwụ.
Ndị otu%
Mgbe ị na-eri nri375.0%
Mgbe ha risịrị nri1

Ndị ọbịa 25 kọọrọ afọ ole ha dị

Ndị otu%
> 60 afọ13
52.0%
Afọ 46-601040.0%
30-45 afọ2

Usoro onunu ogwu:

mbadamba ihe mkpuchi

1 otu mbadamba ihe mkpuchi fim nwere:

Usoro onunu ogwu 2,5 mg + 500 mg:

Ngwaọrụ nọ n'ọrụ: glibenclamide - 2.5 mg, metformin hydrochloride - 500 mg.

Kernel: sodium croscarmellose - 14.0 mg, povidone K 30 - 20,0 mg, microcrystalline cellulose - 56.5 mg, magnesium stearate - 7.0 mg.

Shei: opadry OY-L-24808 pink - 12.0 mg: lactose monohydrate - 36,0%, hypromellose 15cP - 28,0%, titanium dioxide - 24.39%, macrogol - 10.00%, iron oxide, 1, 30%, iron oxide red - 0.3%, iron oxide ojii - 0.010%, mmiri dị ọcha - qs

Usoro onunu ogwu 5 mg + 500 mg:

Ngwaọrụ nọ n'ọrụ: glibenclamide - 5 mg, metformin hydrochloride - 500 mg.

Kernel: sodium croscarmellose - 14.0 mg, povidone K 30 - 20.0 mg, microcrystalline cellulose - 54.0 mg, magnesium stearate - 7.0 mg.

Shei: Opadry 31-F-22700 edo edo - 12.0 mg: lactose monohydrate - 36,0%, hypromellose 15 cP - 28,0%, titanium dioxide - 20.42%, macrogol - 10.00%, quinoline odo - 3 , 00%, iron oxide edo edo - 2,50%, iron oxide red - 0.08%, mmiri dị ọcha - qs.

Nkọwa
Usoro onunu ogwu 2,5 mg + 500 mg: Mbadamba ụrọ biconvex nke kapa, kpuchie ya na ihe nkiri ịke agba nke agba odo na agba, na-ese ihe “2.5” n’otu akụkụ.
Usoro onunu ogwu 5 mg + 500 mg: Mbadamba ụrọ biconvex kapịrị, kpuchie ya na ihe mkpuchi odo, na-ese ihe "5" n'otu akụkụ.

Ngwongwo ogwu

Glucovans ® bụ ngwongwo abụọ nke ọgwụ hypoglycemic nke otu ọgwụ dị iche iche: metformin na glibenclamide.

Metformin bụ otu nke biguanides ma belata ọdịnaya nke basal na postprandial glucose n'ọbara plasma. Metformin anaghị akpali insulin na ya mere ọ bute hypoglycemia. O nwere usoro ihe omume atọ:

  • na-ebelata mmepụta glucose imeju site na igbochi gluconeogenesis na glycogenolysis,
  • na - eme ka mmadụ nwee ike inyocha insulin na - eme ka ndị na - anabata insulin ghara ịba uru ma meekwa ka glucose site na mkpụrụ ndụ akwara ndị ahụ.
  • na-egbu oge itinye glucose na eriri afọ.

    Ọgwụ ahụ nwekwara mmetụta bara uru na ngwakọta nke ọbara, na -ebelata ọkwa nke cholesterol zuru oke, obere lipoproteins dị ala (LDL) na triglycerides.

    Metformin na glibenclamide nwere usoro ọrụ dị iche iche, mana jikọtara ọrụ hypoglycemic ọrụ ibe ha. Njikọ nke ndị na - arụ ọrụ hypoglycemic abụọ nwere mmetụta mmekọrịta na ibelata glucose.

    Mlọ ọgwụ

    Glibenclamide. Mgbe a na -ekwu ya n’onu, iwere si akwara gbasara ihe karịrị 95%. Glibenclamide, nke bụ akụkụ nke ọgwụ Glucovans® bụ micronized. Oke ruru na plasma erutela n’ihe dịka awa anọ, olu nke nkesa dị ihe dịka 10 lita. Nkwukọrịta na protein protein bụ 99%. Ọ fọrọ nke nta ka ọ bụrụ metabolized n'ime imeju na ịmalite nke metabolites abụọ na-adịghị arụ ọrụ, nke akụrụ na-ewepụta (40%) na bile (60%). Iwepu ọkara ndụ bụ site na awa anọ ruo na iri na otu.

    Metformin mgbe nchịkwa ọnụ gasịrị, ọ na-ewepụtakwa ya na eriri afọ nke zuru oke, a na-abanye n'ọtụtụ elu na plasma n'ime awa 2.5. Ihe dị ka 20-30% nke metformin na-apụ apụ site na eriri afọ na-agbanweghị. Ezigbo bioavailability sitere na 50 ruo 60%.

    A na-ekesa Metformin ngwa ngwa na anụ ahụ, ihe fọrọ nke nta ka ọ bụrụ na ọ nweghị ihe nchebe protein. Ọ bụ metadolized ruo obere adịghị ike ma kpụrụ ya akụrụ. Nkebi ọkara ndụ bụ ọkara 6.5. N'ihe banyere ọrụ akụrụ na-emebi emebi, mkpụchapu akwara na-adalata, dịka ikike nhichapụ nke creatinine, ebe mkpochapu ọkara ndụ na-abawanye, nke na-eduga n'ịbawanye ụba nke metformin na plasma ọbara. Nchikota nke metformin na glibenclamide n’otu usoro onodu ogwu nwere otu bioavailability dika mgbe ewere mbadamba ihe dika metformin ma obu glibenclamide n’onwe ya. Mmetụta bioavailability nke metformin yana yana glibenclamide anaghị emetụta nri oriri, yana bioavailability nke glibenclamide. Agbanyeghị, ogo oriri glibenclamide na-abawanye site na nri ị na-eri.

    Ihe ngosi maka ojiji:


    Diabetesdị shuga 2 n'ime ndị okenye:

  • na adighi ike nke usoro nri, mmega ahụ na monotherapy gara aga na usoro metformin ma ọ bụ usoro sulfonylurea,
  • iji dochie ọgwụ gara aga site na iji ọgwụ abụọ (metformin na sulfonylurea derivative) na ndị ọrịa nwere ọkwa glycemia kwụ chịm ma chịkwaa nke ọma.

    Contraindications:

  • hypersensitivity na metformin, glibenclamide ma ọ bụ ihe ndị ọzọ na-eme ka sulfonylurea, yana ihe inyeaka,
  • ụdị shuga 1
  • ọrịa mamịrị ketoacidosis, precca mamịrị, mamịrị shuga,
  • Ihe gbasara akụrụ na-arụ ọrụ ma ọ bụ na-arụ ọrụ ọrịre (mwepụta nke ihe na-erughị 60 ml / min),
  • ọnọdụ ọjọọ nke nwere ike ibute mgbanwe na ọrụ akụrụ: akpịrị ịkpọ nkụ, ọrịa na-efe efe, ujo, intravascular management nke ayodiin nwere ihe dị iche (lee "Ntuziaka Pụrụ Iche"),
  • ọrịa ma ọ bụ ọrịa na-adịghị ala ala nke na-esonyere hypoxia anụ ahụ: obi ma ọ bụ akụkụ okuku ume na -akpata, infarction myocardial na nso nso, ujo,
  • imeju imeju
  • porfria
  • ime, inye ụmụ ara,
  • ojiji nke miconazole,
  • nnukwu ịwa ahụ
  • egbu egbu egbu, ị intoụbiga mmanya ókè
  • lactic acidosis (gụnyere akụkọ ihe mere eme),
  • rube isi na obere kalori (na-erughị calorie 1000 / ụbọchị),

    A naghị atụ aro ka iji ọgwụ ahụ mee ihe na ndị mmadụ karịa afọ 60 bụ ndị na-arụ ọrụ anụ ahụ dị arọ, nke ejikọtara ya na oke ihe ize ndụ nke ịmalite ọrịa lactic acidosis n'ime ha.

    Glucovans ® nwere lactose, yabụ akwadoghị iji ya maka ndị ọrịa nwere ọrịa hereditary ejikọtara na enweghị nkwekọrịta galactose, ụkọ lactase ma ọ bụ glucose-galactose malabsorption syndrome.

    Iji nlezianya: ọrịa febrile, adrenal insufficiency, hypofunction nke isi isi, ọrịa thyroid na uncompensated mebiri nke ọrụ ya.

    Jiri n’oge ime na n’oge a na-enye nwa ara
    Ihe ogwu ahu n’emeghari ime. E kwesiri ịdọ onye ọrịa ahụ aka na ntị na oge ọgwụgwọ ya na Glucovans necessary ọ dị mkpa ịgwa dọkịta banyere atụmatụ ịtụrụ ime na mmalite nke ịtụrụ ime. Mgbe ị na-eme atụmatụ ịtụrụ ime, yana n’ihe gbasara afọ ime n’oge ịluụ ọgwụ Glucovans ®, ọgwụ ahụ kwesịrị ịkwụsị, yana ịnye ọgwụ insulin.

    A na-enye ndị Glucovans in ara ara, n'ihi na onweghị ihe akaebe na-egosi ịbanye na mmiri ara.

    Usoro onunu ogwu na nhazi

    Mkpebi ọgwụ a ka dọkịta kpebiri n’otu n’otu n’otu n’arụrụ onye ọrịa ọ bụla, dabere n’ọkpụkpụ glycemia.

    Ihe mbu bu 1 mbadamba ogwu Glucovans ® 2.5 mg + 500 mg ma obu Glucovans mg 5 mg + 500 mg otu ugboro kwa ubochi. Iji zere hypoglycemia, usoro mbụ ekwesịghị ịgụta kwa ụbọchị nke glibenclamide (ma ọ bụ nha nha nke ọgwụ sulfonylurea ọzọ e meburu) ma ọ bụ metformin, ma ọ bụrụ na ejiri ya mee ihe dị ka usoro ọgwụgwọ mbụ. A na-atụ aro ka ọnụọgụ ahụ rịa elu karịa 5 mg nke glibenclamide + 500 mg nke metformin kwa ụbọchị izu abụọ ma ọ bụ karịa iji nweta nchịkwa glucose ọbara zuru oke.

    Ntinye ogwu eji agwughari ya na metformin na glibenclamide: dose mbụ agaghị agafe kwa ụbọchị nke glibenclamide (ma ọ bụ ihe nha nke nke ọzọ nkwadebe sulfonylurea) na metformin ewere na mbụ. Kwa izu abụọ ma ọ bụ karịa mgbe ịmalite ọgwụgwọ, a na-edozi dose ahụ dabere na ogo nke glycemia.

    Oke kachasị kwa ụbọchị bụ mbadamba 4 nke ọgwụ Glucovans ® 5 mg + 500 mg ma ọ bụ mbadamba 6 nke ọgwụ Glucovans ® 2.5 mg + 500 mg.

    Usoro usoro:
    Usoro usoro usoro onunu ogwu dabere na ebumnuche mmadụ:

    Maka onunu ogwu nke 2.5 mg + 500 mg na 5 mg + 500 mg

  • Otu ugboro n'ụbọchị, n'ụtụtụ n'oge nri ụtụtụ, na-edobe mbadamba 1 kwa ụbọchị.
  • Ugboro abụọ n'ụbọchị, n'ụtụtụ ma na mgbede, na-enwe mbadamba 2 ma ọ bụ 4 kwa ụbọchị.

    Maka usoro onunu ogwu nke 2.5 mg + 500 mg Ugboro atọ n'ụbọchị, n'ụtụtụ, n'ehihie na mgbede, na-enwe mbadamba 3, 5 ma ọ bụ 6 kwa ụbọchị.

    Maka usoro onunu ogwu nke 5 mg + 500 mg Ugboro atọ n'ụbọchị, n'ụtụtụ, n'ehihie na mgbede, na-enwe mbadamba mbadamba 3 kwa ụbọchị.

    E kwesịrị iji nri dị mbadamba. Iri nri ọ bụla nwere carbohydrate kwesịrị ịgbakwunye ya iji gbochie hypoglycemia.

    Ndị okenye na-arịa ọrịa
    A na-ahọrọ ọ̀gwụ nke ọgwụ ahụ dabere na steeti ọrụ arụmọrụ. Ọgwụ nke mbụ ekwesịghị ịfe 1 mbadamba ọgwụ ọgwụ Glukovans ® 2.5 mg + 500 mg. Ntụle oge niile maka ọrụ gbasara akụrụ dị mkpa.

    Childrenmụaka
    A naghị akwadoro Glucovans ® maka ụmụaka.

    Nsonaazụ

    Nsonaazụ ndị na-esote nwere ike ịme n'oge ọgwụgwọ Glucovans ®.

    A na-eme atụmatụ ugboro ole mmetụta ọgwụ ahụ dị ka ndị a:
    Ọtụtụ mgbe: ≥ 1/10
    Ugboro: ≥ 1/100, ® kwesiri ịkwụsị. A na-atụ aro ịmaliteghachi ọgwụgwọ ka awa 48 gachara, naanị mgbe enyochala ma kọwaa ọrụ ezumike.

    Ọrụ akụrụ
    Ebe ọ bụ na akụrụngwa mepụtara metformin, na mgbe nke a gachara, ọ dị mkpa iji chọpụta kọwaa nke creatinine na / ma ọ bụ ihe mejupụtara ya: ọ dịkarịa ala otu ugboro n'afọ na ndị ọrịa nwere ọrụ mkpo nkịtị, yana ugboro 2-4 kwa afọ na ndị ọrịa agadi. , yana ndị ọrịa nwere ikike imebi ya site na oke nke kwesịrị.

    A na-atụ aro oke nlezianya na ọnọdụ ebe enwere ike ịnwe mmekpa ahụ akụrụ, dịka ọmụmaatụ, na ndị ọrịa agadi, ma ọ bụ na mmalite nke usoro ọgwụgwọ antihypertensive, ojiji nke diuretics ma ọ bụ ọgwụ mgbochi mkpali (NSAIDs).

    Prekpachara anya
    Onye ọrịa ga-agwa dọkịta banyere mpụta nke ọrịa bronchopulmonary ma ọ bụ ọrịa na-efe efe nke akụkụ akụkụ ahụ.

    Mmetụta ikike ịkwọ ụgbọ ala ma jiri usoro rụọ ọrụ
    Ekwesịrị ịgwa ndị ọrịa banyere ihe ize ndụ hypoglycemia ma kwesịrị ilezi anya mgbe ha na-anya ma na-arụ ọrụ na-achọkarị mmụba uche na ọsọ nke mmeghachi omume psychomotor.

    Emeputa

    MERC SANTE SAAS
    MERCK SANTE s.a.s.

    Adreesị iwu:
    37 rue Saint-Romain, 69379 LION SEDEX 08, France
    37 rue Saint Romain, 69379 LYON CEDEX 08, France

    Adreesị saịtị:
    Centre de Production SEMOIS, 2 rue du Pressoire Ver, 45400 SEMOIS, France
    Centre de Production SEMOY, 2 rue du Pressoir Vert, 45400 SEMOY, France

    Ekwesịrị izipu ndị na-ere ahịa na:
    LLC Nycomed Distribution Center
    119048 Moscow, nkp. Usacheva, nke 2, p
    Adreesị ịntanetị: www.nycomed.ru

    Ihe omuma a di na peeji ahu sitere n’aka dibia ogwu Vasilieva E.I.

    Edemede na-atọ ụtọ

    Etu ị ga-esi ahọrọ analọg ziri ezi
    Na pharmacology, a na-ekekarị ọgwụ iji mee ka okwu na analogues. Ihe mejuputara ya bu otu uzo ma obu ozo si aru aru nke nwere aru oru aru. Site na analogs bu ọgwụ ndi nwere ihe ndi ozo di ndu, mana ndi mmadu na acho ya.

    Ọdịiche dị n’etiti nje virus na nje
    Ọ bụ nje virus, nje, fungi na protozoa na-ebute ọrịa ndị na-efe efe. Ọrịa na-ebute nje na nje na-abụkarị. Agbanyeghị, ịmata ihe kpatara ọrịa ahụ pụtara ịhọrọ usoro ọgwụgwọ dị mma ga-enyere aka ịnagide ọrịa ngwa ngwa na agaghị emerụ nwa ahụ.

    Ihe nfụkasị bụ ihe na-akpata otutu oge
    Peoplefọdụ ndị maara ọnọdụ nwatakịrị na-arịakarị ụfụ na ogologo oge. Ndị nne na nna na-akpọrọ ya gaa na nke ndị dọkịta, na-ele ule, na-a drugsụ ọgwụ ọjọọ, n'ihi ya, a na-edebanye aha nwatakịrị ahụ na dọkịta ụmụaka mgbe ọ na-arịa ọrịa. Amaghị ihe kpatara ọrịa ọrịa iku ume ugboro ugboro.

    Urology: ọgwụgwọ chlamydial urethritis
    Chlamydial urethritis na-ahụkarị n’omume urologist. Ọ bụ Chlamidia trachomatis nke nje intracellular, nke nwere akụrụngwa nke nje na nje, nke na-achọkarị ọgwụ mgbochi ogologo oge maka ọgwụgwọ antibacterial. O nwere ike ibute oke urera na ụmụ nwoke na ụmụ nwanyị.

    Ahapụ Gị Ikwu